High Fat Diet-Induced Hepatic 18-Carbon Fatty Acids Accumulation Up-Regulates CYP2A5/CYP2A6 via NF-E2-Related Factor 2.
- Authors
- Wang, Xing-He; Cui, Xiao-Xu; Sun, Xiao-Qi; Wang, Xing-Hui; Li, Xiao-Chong; Qi, Yue; Li, Wei; Han, Mei-Yu; Muhammad, Ishfaq; Zhang, Xiu-Ying
- Year
- 2017
- Journal
- Frontiers in pharmacology
- PMID
- 28555106
- DOI
- 10.3389/fphar.2017.00233
- PMCID
- PMC5431014
To investigate the role of hepatic 18-carbon fatty acids (FA) accumulation in regulating CYP2A5/2A6 and the significance of Nrf2 in the process during hepatocytes steatosis, Nrf2-null, and wild type mice fed with high-fat diet (HFD), and Nrf2 silenced or over expressed HepG2 cells administered with 18-carbon FA were used. HE and Oil Red O staining were used for mice hepatic pathological examination. The mRNA and protein expressions were measured with real-time PCR and Western blot. The results showed that hepatic CYP2A5 and Nrf2 expression levels were increased in HFD fed mice accompanied with hepatic 18-carbon FA accumulation. The Nrf2 expression was increased dose-dependently in cells administered with increasing concentrations of stearic acid, oleic acid, and alpha-linolenic acid. The Nrf2 expression was dose-dependently decreased in cells treated with increasing concentrations of linoleic acid, but the Nrf2 expression level was still found higher than the control cells. The CYP2A6 expression was increased dose-dependently in increasing 18-carbon FA treated cells. The HFD-induced up-regulation of hepatic CYP2A5 and the 18-carbon FA treatment induced up-regulation of CYP2A6 in HepG2 cells were, respectively, inhibited by Nrf2 deficiency and Nrf2 silencing. While the basal expression of mouse hepatic CYP2A5 was not impeded by Nrf2 deletion. Nrf2 over expression improved the up-regulation of CYP2A6 induced by 18-carbon FA. As the classical target gene of Nrf2, mRNA relative expression was increased in Nrf2 over expressed cells and was decreased in Nrf2 silenced cells. In presence or absence of 18-carbon FA treatment, the change of CYP2A6 expression level was similar to in Nrf2 silenced or over expressed HepG2 cells. It was concluded that HFD-induced hepatic 18-carbon FA accumulation contributes to the up-regulation of CYP2A5/2A6 via activating Nrf2. However, the CYP2A5/2A6 expression does not only depend on Nrf2.
Mouse hepatic pathology. Liver sections of the former four figures were stained by hematoxylin and eosin. Liver sections of the latter four figures were stained with Oil Red O and the fat accumulated in hepatocytes manifested red. All the liver sections were examined by light microscopy and the images were displayed at 200Γ the original magnification. The fat accumulation in hepatocytes were pointed out by the arrows in HFD groups.
Nrf2 and CYP2A5 protein expressions in HFD feeding mice. Nrf2 protein expression in mouse hepatocytes nucleus and its quantity relative to Histon H1 is shown in panel (A). Nrf2 protein expression in liver cytoplasm and its quantity relative to Ξ²-actin is shown in panel (B). Hepatic CYP2A5 protein expression in WT and Nrf2-null mice, which fed with CD and HFD, is revealed in panel (C) and the quantity relative to Ξ²-actin is shown in panel (D). * represent statistical difference caused by HFD within WT or Nrf2-null groups; $ represent statistical difference caused by Nrf2 deficiency on the same diet. * 0.01 < P < 0.05, **P < 0.01; $ 0.01 < P < 0.05, $$P < 0.01.
Effect of 18-carbon fatty acid on Nrf2 and CYP2A6 expression in HepG2 cells. (A) HepG2 cells viability which were administered with increasing concentrations of SA, OA, LA, and ALA. The cells viability was represented by the absorbance. The effect of SA, OA, LA, and ALA on Nrf2 and CYP2A6 protein expression in HepG2 cells are exhibited in panel (B). Nrf2 protein expression was quantified and shown in panel (C). CYP2A6 protein expression was quantified and shown in panel (D). The effect of SA, OA, LA, and ALA on Nrf2 and CYP2A6 mRNA expressions are shown in panel (E,F), respectively. Asterisks * represent statistical difference caused by fatty acid administration from control cells. * 0.01< P < 0.05, **P < 0.01.
Nrf2 gene silence and over expression. In Nrf2 siRNA transfected HepG2 cells, Nrf2 protein expression is shown in panel (A) and its quantity relative to Ξ²-actin is shown in panel (B); Nrf2 mRNA expression is shown in panel (C). In pcDNA3-EGFP-C4-Nrf2 transfected HepG2 cells, Nrf2 protein expression is shown in panel (D) and its quantity relative to Ξ²-actin is shown in panel (E); Nrf2 mRNA expression is shown in panel (F). The GSTA1 mRNA relative expression in different groups was shown in panel (G). NC, in panel (AβC) represents the HepG2 cells that transfected with negative control siRNA, in panel (DβF) represents the HepG2 cells that transfected with negative control plasmid (pcDNA3-EGFP-C4). In panel (G), NC-O represents the cells that transfected with pcDNA3-EGFP-C4 and NC-S represents the HepG2 cells that transfected with negative control siRNA. Cell, means the control cells that without any administration. Asterisks * represent statistical difference caused by Nrf2 siRNA or pcDNA3-EGFP-C4-Nrf2 transfection from control cells without any stimulation. * 0.01< P < 0.05, **P < 0.01.
CYP2A6 and GSTA1 expression changes in Nrf2 silenced and over-expressed HepG2 cells administered with LA and ALA. CYP2A6 mRNA (A) and protein (B,C) expressions were both decreased significantly in Nrf2 silenced cells with or without LA and ALA treatment. CYP2A6 mRNA (D) and protein (E,F) expressions were increased in Nrf2 over-expressed cells with or without LA and ALA administration. In the presence or absence of LA and ALA administration, GSTA1 mRNA expression was down-regulated in cells transfected with Nrf2 siRNA (G) and was up-regulated in cells transfected with pcDNA3-EGFP-C4-Nrf2 (H). In addition, the NC cells in panel (AβC,G) were transfected with NC siRNA. The NC cells in panel (DβF,H) were transfected with NC plasmid (pcDNA3-EGFP-C4). * represent statistical difference caused by transfection of Nrf2 siRNA and pcDNA3-EGFP-C4-Nrf2 from cells transfected with NC siRNA and NC plasmid; $ represent statistical difference caused by LA and ALA administration within Nrf2 silenced cells, Nrf2 over expressed cells, and control cells. *0.01 < P < 0.05, **P < 0.01; $ 0.01 < P < 0.05, $$P < 0.01.
No entities extracted from this document yet.
No uploaded files.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| Abu-BakarA.LΓ€msΓ€V.ArpiainenS.MooreM. R.LangM. A.HakkolaJ. (2007). Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2. Drug Metab. Dispos. 35, 787β794. 10.1124/dmd.106.01442317303623 | β | β | β |
| Abu-BakarA.SatarugS.MarksG. C.LangM. A.MooreM. R. (2004). Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2. Toxicol. Lett. 148, 199β210. 10.1016/j.toxlet.2003.10.02915041070 | β | β | β |
| AnguloP. (2002). Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221β1231. 10.1056/NEJMra01177511961152 | β | β | β |
| ArpiainenS.Raffalli-MathieuF.LangM. A.PelkonenO.HakkolaJ. (2005). Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway. Mol. Pharmacol. 67, 1325β1333. 10.1124/mol.104.00807815657367 | β | β | β |
| BhalaN.JounessR. I.BugianesiE. (2013). Epidemiology and natural history of patients with NAFLD. Curr. Pharm. Des. 19, 5169β5176. 10.2174/1381612811319999033623394091 | β | β | β |
| BugianesiE.LeoneN.VanniE.MarchesiniG.BrunelloF.CarucciP.. (2002). Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123, 134β140. 10.1053/gast.2002.3416812105842 | β | β | β |
| Camus-RandonA. M.GenesteO.HonkakoskiP.BΓ©rΓ©ziatJ. C.HendersonC. J.WolfC. R. (1993). High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol. Carcinog. 7, 268β275. 10.1002/mc.29400704108352885 | β | β | β |
| Camus-RandonA. M.RaffalliF.BΓ©rΓ©ziatJ. C.McGregorD.KonstandiM.LangM. A. (1996). Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes. Toxicol. Appl. Pharmacol. 138, 140β148. 865850310.1006/taap.1996.0107 | β | β | β |
| ChaoP. M.KuoY. H.LinY. S.ChenC. H.ChenS. W.KuoY. H. (2010). The metabolic benefits of Polygonum hypoleucum Ohwi in HepG2 cells and Wistar rats under lipogenic stress. J. Agric. Food. Chem. 58, 5174β5180. 10.1021/jf100046h20230058 | β | β | β |
| Chavez-TapiaN. C.RossoN.TiribelliC. (2011). In vitro models for the study of non-alcoholic fatty liver disease. Curr. Med. Chem. 18, 1079β1084. 10.2174/09298671179494084221254970 | β | β | β |
| ChowdhryS.NazmyM. H.MeakinP. J.Dinkova-KostovaA. T.WalshS. V.TsujitaT.. (2010). Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic. Biol. Med. 48, 357β371. 10.1016/j.freeradbiomed.2009.11.00719914374 | β | β | β |
| CuiY.WangQ.YiX.ZhangX. (2016). Effects of fatty acids on CYP2A5 and Nrf2 expression in mouse primary hepatocytes. Biochem. Genet. 54, 29β40. 10.1007/s10528-015-9697-626423681 | β | β | β |
| FeliciaN. D.RekhaG. K.MurphyS. E. (2000). Characterization of cytochrome P450 2A4 and 2A5-catalyzed 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism. Arch. Biochem. Biophys. 384, 418β424. 10.1006/abbi.2000.212811368333 | β | β | β |
| FurumotoH.NanthirudjanarT.KumeT.IzumiY.ParkS. B.KitamuraN.. (2016). 10-Oxo-trans-11-octadecenoic acid generated from linoleic acid by a gut lactic acid bacterium Lactobacillus plantarum is cytoprotective against oxidative stress. Toxicol. Appl. Pharmacol. 296, 1β9. 10.1016/j.taap.2016.02.01226879219 | β | β | β |
| JnoffE.AlbrechtC.BarkerJ. J.BarkerO.BeaumontE.BromidgeS.. (2014). Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complex. Chem. Med. Chem. 9, 699β705. 10.1002/cmdc.20130052524504667 | β | β | β |
| JounaidiY.BonfilsC.PerinF.NegishiM.LangeR. (1994). Overexpression of a cytochrome P-450 of the 2a family (Cyp2a-5) in chemically induced hepatomas from female mice. Eur. J. Biochem. 219, 791β798. 10.1111/j.1432-1033.1994.tb18559.x8112330 | β | β | β |
| KirbyG. M.CheminI.MontesanoR.ChisariF. V.LangM. A.WildC. P. (1994b). Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol. Carcinog. 11, 74β80. 10.1002/mc.29401102047916995 | β | β | β |
| KirbyG. M.PelkonenP.VatanasaptV.CamusA. M.WildC. P.LangM. A. (1994a). Association of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver. Mol. Carcinog. 11, 81β89. 10.1002/mc.29401102057916996 | β | β | β |
| KojimaS.WatanabeN.NumataM.OgawaT.MatsuzakiS. (2003). Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J. Gastroenterol. 38, 954β961. 10.1007/s00535-003-1178-814614602 | β | β | β |
| KojoA.ViitalaP.PasanenM.PelkonenO.RaunioH.JuvonenR. (1998). Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes. Arch. Toxicol. 72, 336β341. 10.1007/s0020400505119657280 | β | β | β |
| LΓ€msΓ€V.LevonenA. L.LeinonenH.YlΓ€-HerttualaS.YamamotoM.HakkolaJ. (2010). Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver. Chem. Res. Toxicol. 23, 977β985. 10.1021/tx100084c20402460 | β | β | β |
| MarchesiniG.BugianesiE.ForlaniG.CerrelliF.LenziM.ManiniR.. (2003). Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917β923. 10.1053/jhep.2003.5016112668987 | β | β | β |
| MeakinP. J.ChowdhryS.SharmaR. S.AshfordF. B.WalshS. V.McCrimmonR. J. (2014). Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol. Cell. Biol. 34, 3305β3320. 10.1128/MCB.00677-1424958099PMC4135558 | β | β | β |
| MollicaM. P.TrincheseG.CavaliereG.de FilippoC.CoccaE.GaitaM.. (2014). c9,t11-Conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway. J. Lipid Res. 55, 837β849. 10.1194/jlr.M04403224634500PMC3995462 | β | β | β |
| MonteroR.GentileG. J.FrederickL.McMannisJ.MurphyT.SilvaG.. (1999). Induced expression of CYP2A5 in inflamed trematode-infested mouse liver. Mutagenesis 14, 217β220. 10.1093/mutage/14.2.21710229924 | β | β | β |
| OnicaT.NicholsK.LarinM.NgL.MaslenA.DvorakZ.. (2008). Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 to the proximal promoter. Mol. Pharmacol. 73, 451β460. 10.1124/mol.107.03935417978169 | β | β | β |
| OyakeT.ItohK.MotohashiH.HayashiN.HoshinoH.NishizawaM.. (1996). Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16, 6083β6095. 10.1128/mcb.16.11.60838887638PMC231611 | β | β | β |
| PelkonenP.LangM. A.NegishiM.WildC. P.JuvonenR. O. (1997). Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity. Chem. Res. Toxicol. 10, 85β90. 10.1021/tx960078m9074807 | β | β | β |
| RaunioH.JuvonenR.PasanenM.PelkonenO.PaakkoP.SoiniY. (1998). Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma. Hepatology 27, 427β432. 10.1002/hep.5102702179462641 | β | β | β |
| SalonpÀÀP.KottariS.PelkonenO.RaunioH. (1997). Regulation of CYP2A5 induction by porphyrinogenic agents in mouse primary hepatocytes. Naunyn. Schmiedebergs Arch. Pharmacol. 355, 8β13.900783610.1007/pl00004922 | β | β | β |
| ShimozonoR.AsaokaY.YoshizawaY.AokiT.NodaH.YamadaM.. (2013). Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model. Mol. Pharmacol. 84, 62β70. 10.1124/mol.112.08426923592516 | β | β | β |
| SipowiczM. A.ChomaratP.DiwanB. A.AnverM. A.AwasthiY. C.WardJ. M. (1997). Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with helicobacter hepaticus. Am. J. Pathol. 15, 933β941.PMC18580289327726 | β | β | β |
| SugimotoH.OkadaK.ShodaJ.WarabiE.IshgeK.UedaT.. (2010). Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G283βG294. 10.1152/ajpgi.00296.200919926817 | β | β | β |
| WakabayashiN.Dinkova-KostovaA. T.HoltzclawW. D.KangM. I.KobayashiA.YamamotoM.. (2004). Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U.S.A. 101, 2040β2045. 10.1073/pnas.030730110114764894PMC357048 | β | β | β |
| WangC.TaoQ.WangX. H.WangX. R.ZhangX. (2016). Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease. Environ. Toxicol. Pharmacol. 45, 52β62. 10.1016/j.etap.2016.05.01427262986 | β | β | β |
| WangX.LiC.XuS.MuhammadI.ZhangX. (2016). NF-E2-related factor 2 deletion facilitates hepatic fatty acids metabolism disorder induced by high-fat diet via regulating related genes in mice. Food Chem. Toxicol. 94, 186β196. 10.1016/j.fct.2016.06.01127311796 | β | β | β |
| YaoH. R.LiuJ.PlumeriD.CaoY. B.HeT.LinL.. (2011). Lipotoxicity in HepG2 cells triggered by free fatty acids. Am. J. Transl. Res. 3, 284β291. 21654881PMC3102573 | β | β | β |
| YonedaC.OginoJ.MatsuuraH.HarukiT.SuzukiY.HashimotoN. (2012). Increased prevalence of diabetic complications in Japanese patients with type 1 diabetes and nonalcoholic fatty liver disease. Diabetol. Int. 3, 37β41. 10.1007/s13340-011-0061-8 | β | β | β |
| ZengY. Y.JiangW. D.LiuY.WuP.ZhaoJ.JiangJ.. (2016). Dietary alpha-linolenic acid/linoleic acid ratios modulate intestinal immunity, tight junctions, anti-oxidant status and mRNA levels of NF-ΞΊB p65, MLCK and Nrf2 in juvenile grass carp (Ctenopharyngodon idella). Fish Shellfish Immunol. 51, 351β364. 10.1016/j.fsi.2015.11.02626615102 | β | β | β |
| ZhukovaN. V.NovgorodtsevaT. P.DenisenkoY. K. (2014). Effect of the prolonged high-fat diet on the fatty acid metabolism in rat blood and liver. Lipids Health Dis. 13:49. 10.1186/1476-511X-13-4924628762PMC3995525 | β | β | β |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | 2019 | 29568101 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Aflatoxin B1-Induced male reproductive Toxicity: Bioactivation, mechanisms, molecular pathways, and Mitigation by phytochemicals in humans and animals. | Zhu Z et al. | β | 2025 | β |
| Argan Oil: A Natural Bioactive Lipid Modulating Oxidative Stress and Inflammation. | Rabbaa S et al. | β | 2025 | β |
| The Potential Role of Major Argan Oil Compounds as Nrf2 Regulators and Their Antioxidant Effects. | El Kebbaj R et al. | β | 2024 | β |
| Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1. | Jiang J et al. | β | 2024 | β |
| The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice. | Zhu Y et al. | β | 2023 | β |
| SpatialDEG: Identification of differentially expressed genes by leveraging spatial information in spatially resolved transcriptomic studies | Yang Y et al. | β | 2022 | β |
| Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms. | Shaw P et al. | β | 2020 | β |
| NRF2 as a regulator of cell metabolism and inflammation in cancer. | He F et al. | β | 2020 | β |
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | Wang K et al. | β | 2019 | β |
| Cytochrome P450s and Alcoholic Liver Disease. | Lu Y et al. | β | 2018 | β |